EDITORIAL
MITRA-FR: speed bump or end of the road for percutaneous mitral repair in secondary mitral regurgitation?
October 19, 2018 | 10.4244/EIJV14I8A149
Percutaneous repair of sinus venosus ASD: the end of congenital cardiac surgery?
October 19, 2018 | 10.4244/EIJV14I8A150
Transcatheter aortic valve looking for low-risk patients: a post hoc analysis of SURTAVI keeps opening the door
October 19, 2018 | 10.4244/EIJV14I8A151
From saline to serial FFR measurement - the continued rationale for physiological stenosis assessment in stable coronary artery disease
October 19, 2018 | 10.4244/EIJV14I8A152
PERSPECTIVES
Invasive cardiovascular needs in South Africa: a view from afar up close
October 19, 2018 | 10.4244/EIJV14I8A153
INTERVENTIONS FOR VALVULAR DISEASE AND HEART FAILURE
CLINICAL RESEARCH
Long-term effectiveness and safety of transcatheter closure of patent foramen ovale compared with antithrombotic therapy alone: a meta-analysis of six randomised clinical trials and 3,560 patients with reconstructed time-to-event data October 19, 2018 | 10.4244/EIJ-D-18-00341
CLINICAL RESEARCH
Early experience of transcatheter correction of superior sinus venosus atrial septal defect with partial anomalous pulmonary venous drainage October 19, 2018 | 10.4244/EIJ-D-18-00304
CLINICAL RESEARCH
One-year outcomes of patients with severe aortic stenosis and an STS PROM of less than three percent in the SURTAVI trial October 19, 2018 | 10.4244/EIJ-D-18-00460
INTERVENTIONAL FLASHLIGHT
Bioprosthetic Aortic Scallop Intentional Laceration to prevent Iatrogenic Coronary Artery obstruction (BASILICA) during transcatheter aortic valve-in-valve implantation with bioprosthetic valve fracturing via the transcaval access October 19, 2018 | 10.4244/EIJ-D-18-00553
CLINICAL RESEARCH
Early commercial experience from transcatheter aortic valve implantation using the Portico™ bioprosthetic valve: 30-day outcomes in the multicentre PORTICO-1 study October 19, 2018 | 10.4244/EIJ-D-18-00343
INTERVENTIONAL FLASHLIGHT
Main pulmonary artery perforations after left atrial appendage occluder implantation October 19, 2018 | 10.4244/EIJ-D-18-00419
INTERVENTIONS FOR HYPERTENSION AND STROKE
INTERVENTIONAL FLASHLIGHT
Ultra-low contrast percutaneous coronary intervention in patients with severe chronic kidney disease October 19, 2018 | 10.4244/EIJ-D-17-00774
CORONARY INTERVENTIONS
CLINICAL RESEARCH
Saline-induced Pd/Pa ratio predicts functional significance of coronary stenosis assessed using fractional flow reserve October 19, 2018 | 10.4244/EIJ-D-17-01010
CLINICAL RESEARCH
Coronary lesion progression as assessed by fractional flow reserve (FFR) and angiography October 19, 2018 | 10.4244/EIJ-D-17-00872
CLINICAL RESEARCH
Two-year clinical outcome of all-comers treated with three highly dissimilar contemporary coronary drug-eluting stents in the randomised BIO-RESORT trial October 19, 2018 | 10.4244/EIJ-D-18-00336
INTERVENTIONAL FLASHLIGHT
Non-invasive treatment planning of tandem coronary artery lesions using an interactive planner for PCI October 19, 2018 | 10.4244/EIJ-D-17-00815
CLINICAL RESEARCH
One-year rehospitalisation after percutaneous coronary intervention: a retrospective analysis October 19, 2018 | 10.4244/EIJ-D-17-00800
CLINICAL RESEARCH
The impact of Objective Mathematical Analysis during Fractional Flow Reserve measurement: results from the OMA-FFR study October 19, 2018 | 10.4244/EIJ-D-17-00826
CLINICAL RESEARCH
Less invasive fractional flow reserve measurement from 3-dimensional quantitative coronary angiography and classic fluid dynamic equations October 19, 2018 | 10.4244/EIJ-D-17-00859
FOCUS ARTICLE
Will ORBITA change my practice? ORBITA trial: Objective Randomised Blinded Investigation with optimal medical Therapy of Angioplasty in stable angina
October 19, 2018 | 10.4244/EIJY18M09_2